ZIMMER BIOMET HOLDINGS, INC. Payments of Debt Issuance Costs
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Payments of Debt Issuance Costs of $1.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-05
- ZIMMER BIOMET HOLDINGS, INC. payments of debt issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. payments of debt issuance costs for the quarter ending 2025-09-30 was $5.40M.
- ZIMMER BIOMET HOLDINGS, INC. payments of debt issuance costs for the quarter ending 2025-06-30 was $1.20M.
- ZIMMER BIOMET HOLDINGS, INC. payments of debt issuance costs for the quarter ending 2025-03-31 was $16.10M.
- ZIMMER BIOMET HOLDINGS, INC. payments of debt issuance costs for fiscal 2025 was $22.70M, a 74.62% increase from fiscal 2024.
- ZIMMER BIOMET HOLDINGS, INC. payments of debt issuance costs for fiscal 2024 was $13.00M, a 124.14% increase from fiscal 2023.
- ZIMMER BIOMET HOLDINGS, INC. payments of debt issuance costs for fiscal 2023 was $5.80M, a 262.50% increase from fiscal 2022.
- ZIMMER BIOMET HOLDINGS, INC. payments of debt issuance costs for fiscal 2022 was $1.60M.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.30M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $5.40M derived: sum of 2 quarters · filed 2026-02-20 | $6.60M derived: sum of 3 quarters · filed 2026-08-05 | $22.70M 10-K · filed 2026-02-20 |
| 2025-09-30 | $5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.60M derived: sum of 2 quarters · filed 2026-08-05 | $22.70M 10-Q · filed 2025-11-05 | $27.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $17.30M 10-Q · filed 2026-08-05 | $22.40M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-03-31 | $16.10M 10-Q · filed 2026-05-01 | $21.20M derived: sum of 2 quarters · filed 2026-05-01 | ||
| 2024-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $13.00M 10-K · filed 2026-02-20 | ||
| 2024-09-30 | $7.90M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $5.80M 10-K · filed 2026-02-20 | |||
| 2022-12-31 | $1.60M 10-K · filed 2025-02-25 | |||
| 2021-12-31 | $11.70M derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | $13.20M 8-K · filed 2024-08-07 | ||
| 2021-09-30 | $1.50M 10-Q · filed 2021-11-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $2.90M derived: sum of 2 quarters · filed 2023-02-24 | $10.10M derived: sum of 3 quarters · filed 2023-02-24 | $22.30M 10-K · filed 2023-02-24 |
| 2020-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $10.10M derived: sum of 2 quarters · filed 2021-11-04 | $22.30M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $19.40M 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $12.20M 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $3.50M 8-K · filed 2022-06-22 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $0.00 derived: sum of 2 quarters · filed 2021-02-22 | $0.00 derived: sum of 3 quarters · filed 2021-02-22 | $4.90M 10-K · filed 2021-02-22 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $4.90M 10-Q · filed 2018-11-01 | $4.90M derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $4.90M 10-Q · filed 2018-08-06 | $4.90M derived: sum of 3 quarters · filed 2018-08-06 | |
| 2018-03-31 | $4.90M 10-Q · filed 2018-05-08 | $4.90M derived: sum of 2 quarters · filed 2018-05-08 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $300.00K 10-K · filed 2018-02-27 | ||
| 2017-09-30 | $300.00K 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $10.00M 10-K · filed 2018-02-27 | ||
| 2016-09-30 | $3.40M 10-Q · filed 2017-11-06 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $58.40M 10-K · filed 2018-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $58.40M 10-Q · filed 2016-11-08 | $58.40M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $58.40M 10-Q · filed 2016-08-08 | $58.40M derived: sum of 3 quarters · filed 2017-03-01 | $74.80M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $58.40M 10-Q · filed 2016-05-10 | $58.40M derived: sum of 2 quarters · filed 2017-03-01 | $74.80M derived: sum of 3 quarters · filed 2017-03-01 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $16.40M derived: sum of 2 quarters · filed 2017-03-01 | $64.10M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $16.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $64.10M 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $47.70M 10-Q · filed 2015-08-10 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $0.00 derived: sum of 2 quarters · filed 2015-02-23 | $3.30M 10-K · filed 2015-02-23 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $3.30M 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $3.30M 10-Q · filed 2013-08-07 | |||
| 2011-12-31 | $4.00M 10-K · filed 2014-02-28 | |||
| 2009-12-31 | $8.50M 10-K · filed 2012-02-27 | |||
| 2008-12-31 | $0.00 10-K · filed 2010-02-25 | |||
| 2007-12-31 | $0.00 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |